AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Rentokil Initial PLC

Director's Dealing May 21, 2020

5305_dirs_2020-05-21_e15075c6-0f13-4c9b-905b-c16587644370.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6296N

Rentokil Initial PLC

21 May 2020

Rentokil Initial plc (the Company)

The relevant notification set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Vanessa Evans

2

Reason for the notification

a)

Position/status

Group HR Director (PDMR)

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rentokil Initial plc

b)

LEI

549300VN4WV7Z6T14K68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

ISIN: GB00B082RF11

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
£4.9908 115,890

d)

Aggregated information

- Aggregated volume

- Price

115,890

£578,383.81

e)

Date of the transaction

20 May 2020

f)

Place of the transaction

London Stock Exchange (XLON)

Enquiries:

Daragh Fagan, Company Secretary              Rentokil Initial plc             01276 607444

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGCGDUCSDDGGB

Talk to a Data Expert

Have a question? We'll get back to you promptly.